We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
6-Chloro-3-nitro-2-[(phenylsulfonyl)methyl]imidazo[1,2- b ]pyridazine.
- Authors
Paoli-Lombardo, Romain; Primas, Nicolas; Hutter, Sébastien; Bourgeade-Delmas, Sandra; Boudot, Clotilde; Castera-Ducros, Caroline; Jacquet, Inès; Courtioux, Bertrand; Azas, Nadine; Rathelot, Pascal; Vanelle, Patrice
- Abstract
As part of our ongoing scaffold-hopping work on an antikinetoplastid 3-nitroimidazo[1,2-a]pyridine scaffold, we explored 3-nitroimidazo[1,2-b]pyridazine as a potential new antikinetoplastid series. Using conditions previously described by our lab, we obtained 6-chloro-3-nitro-2-[(phenylsulfonyl)methyl]imidazo[1,2-b]pyridazine with 54% yield. In vitro activity of this compound was evaluated against both the promastigote form of Leishmania donovani, the axenic amastigote form of Leishmania infantum and the trypomastigote blood stream form of Trypanosomabrucei brucei, and its influence on cell viability was assessed on the HepG2 cell line. However, despite good activity against the trypomastigote blood stream form of T. b. brucei (EC50 = 0.38 µM), it showed poor solubility in both HepG2 (CC50 > 7.8 µM) and L. infantum axenic amastigotes (EC50 > 1.6 µM) culture media, associated with a loss of activity against the promastigote form of L. infantum (EC50 > 15.6 µM).
- Subjects
AMASTIGOTES; PYRIDAZINES; LEISHMANIA donovani; LEISHMANIA infantum; CELL survival; CELL lines
- Publication
Molbank, 2023, Vol 2023, Issue 1, pM1573
- ISSN
1422-8599
- Publication type
Article
- DOI
10.3390/M1573